| Overview |
| bsm-62172r-Cy5.5-100ul |
| PRKRA Recombinant Antibody, Cy5.5 Conjugated |
| WB, IF |
| Human, Mouse, Rat |
| Specifications |
| Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human PRKRA |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 8575 |
| O75569 |
| Cytoplasm |
| RAX; PACT; DYT16; HSD14. |
| Activates EIF2AK2/PKR in the absence of double-stranded RNA (dsRNA), leading to phosphorylation of EIF2S1/EFI2-alpha and inhibition of translation and induction of apoptosis. Required for siRNA production by DICER1 and for subsequent siRNA-mediated post-transcriptional gene silencing. |
| Application Dilution |
| WB |
1:300-5000 |
| IF |
|
Powered by Bioz